Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma

por Zhang, H, Su, L, Müller, S, Tighiouart, M, Xu, Z, Zhang, X, Shin, H J C, Hunt, J, Sun, S-Y, Shin, D M, Chen, Z(G)
Publicado 2008

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies

por Harvey, R D, Owonikoko, T K, Lewis, C M, Akintayo, A, Chen, Z, Tighiouart, M, Ramalingam, S S, Fanucchi, M P, Nadella, P, Rogatko, A, Shin, D M, El-Rayes, B, Khuri, F R, Kauh, J S
Publicado 2013

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer

por Tuli, R., Shiao, S.L., Nissen, N., Tighiouart, M., Kim, S., Osipov, A., Bryant, M., Ristow, L., Placencio-Hickok, V.R., Hoffman, D., Rokhsar, S., Scher, K., Klempner, S.J., Noe, P., Davis, M.J., Wachsman, A., Lo, S., Jamil, L., Sandler, H., Piantadosi, S., Hendifar, A.
Publicado 2019